- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Transmembrane domains.
Displaying page 1 of 1.
EudraCT Number: 2015-000395-97 | Sponsor Protocol Number: GS-US-205-0117 | Start Date*: 2015-02-02 |
Sponsor Name:Gilead Sciences, Inc. [...] | ||
Full Title: A Double-Blind, Multicenter, Multinational, Randomized, Placebo-Controlled Trial Evaluating Aztreonam Lysine for Inhalation in Patients with Cystic Fibrosis, Mild Lung Disease, and P. aeruginosa (A... | ||
Medical condition: Cystic Fibrosis with Mild Lung Disease and P. aeruginosa (AIR-CF4) | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2010-019634-26 | Sponsor Protocol Number: MPEX-209 | Start Date*: 2011-05-24 | ||||||||||||||||
Sponsor Name:Mpex Pharmaceuticals, Inc. | ||||||||||||||||||
Full Title: A Phase 3, Open-Label, Randomized Trial to Evaluate the Safety and Efficacy of MP-376 Inhalation Solution (Aeroquinâ„¢) versus Tobramycin Inhalation Solution (TIS) in Stable Cystic Fibrosis Patients | ||||||||||||||||||
Medical condition: Pseudomonas aeruginosa infection in patients suffering from stable Cystic Fibrosis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) GB (Completed) FR (Ongoing) IE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-004277-26 | Sponsor Protocol Number: GS-US-205-0110 | Start Date*: 2008-04-29 | |||||||||||
Sponsor Name:Gilead Sciences Inc | |||||||||||||
Full Title: An Open-Label, Randomized, Phase 3 Trial to Evaluate the Efficacy and Safety of Aztreonam 75 mg Powder and Diluent for Nebuliser Solution (AZLI) versus Tobramycin Nebuliser Solution (TNS) in an Int... | |||||||||||||
Medical condition: Adult and paediatric cystic fibrosis (CF) patients with pulmonary Pseudomonas aeruginosa (PA) infection. | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) FR (Completed) ES (Completed) GB (Completed) IE (Completed) DK (Completed) DE (Completed) NL (Completed) IT (Completed) PT (Completed) AT (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011740-19 | Sponsor Protocol Number: GS-US-205-0127 | Start Date*: 2015-02-02 | |||||||||||
Sponsor Name:Gilead Sciences, Inc. | |||||||||||||
Full Title: Phase 3b Randomized, Double-Blind, Placebo-Controlled Two-Part Trial to Assess the Safety and Efficacy of Continuous Aztreonam for Inhalation Solution (AZLI) in Subjects with Cystic Fibrosis (CF) a... | |||||||||||||
Medical condition: Cystic Fibrosis subjects with chronic Burkholderia spp. infection of the airways. | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
